Prostate Cancer Early Detection – Version 2.2016

Year: 2016

AGREE II score: Available

Developer organization: National Comprehensive Cancer Network

Type of cancer: Genitourinary, Prostate

Patient population: Adult

Location: International

This is a clinical practice guideline for healthy male patients who have elected to participate in early screening of prostate cancer. The guideline reviews types of early detection testing, mainly PSA and DRE, provides recommendations on baseline evaluation, risk assessment, and early detection evaluation, provides guidance on indications for biopsy and direction for management of biopsy results. Special topics of interest include biomarker testing and biopsy technique.